Off-label Use of Biologics in Urticarial Vasculitis: A European Cohort Study

被引:0
|
作者
Maisonobe, Lucas [1 ]
Korganow, Anne-Sophie [2 ]
Berti, Alvise [3 ]
Deroux, Alban [4 ]
Dupin, Nicolas [5 ]
Aractingi, Selim [5 ]
Emmi, Giacomo [6 ]
Vandergheynst, Frederic [7 ]
Fabre, Marc [8 ]
Kluger, Nicolas [9 ]
Roux, Marielle [8 ]
Abisror, Noemie [10 ]
Benyamine, Audrey [11 ]
Cassone, Giulia [12 ]
Chasset, Francois [13 ]
Doutre, Marie-Sylvie [14 ]
Foucher, Aurelie [15 ]
Freguin, Caroline [16 ]
Gobert, Delphine [17 ]
Gombeir, Yannick [7 ]
Hernandez-Rodriguez, Jose [18 ]
Legouellec, Noemie [19 ]
Pinault, Anne-Lise [20 ]
Titeca-Beauport, Dimitri [21 ]
Jachiet, Marie [22 ]
Terrier, Benjamin [23 ]
机构
[1] AP HP, Paris, France
[2] Strasbourg Univ Hosp, Strasbourg, France
[3] Univ Trento, Rochester, MN USA
[4] CHU Grenoble, Grenoble, France
[5] CHU Cochin, Paris, France
[6] Univ Florence, Florence, Italy
[7] Univ Libre Bruxelles, Brussels, Belgium
[8] Ctr Hosp Pierre Oudot, Bourgoin Jallieu, France
[9] Univ Helsinki, Cent Hosp, Helsinki, Finland
[10] St Antoine Hosp, Internal Med, Paris, France
[11] Hop Nord Marseille, Marseille, France
[12] Univ Modena & Reggio Emilia, Modena, Italy
[13] Tenon Hosp, Dermatol Dept, Paris, France
[14] CHU Bordeaux, Bordeaux, France
[15] CHU Reunion, St Pierre, France
[16] Ctr Hosp St Brieuc, St Brieux, France
[17] CHU St Atoine, Paris, France
[18] Hosp Clin Barcelona, Barcelona, Spain
[19] Ctr Hosp Valenciennes, Valenciennes, France
[20] Ctr Hosp Epinal, Epinal, France
[21] CHU Amiens, Amiens, France
[22] CHU St Louis, Paris, France
[23] Hop Cochin, AP HP, Dept Internal Med, Paris, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0694
引用
收藏
页码:1379 / 1380
页数:2
相关论文
共 50 条
  • [31] Methylphenidate Off-label Use
    Trenque, T.
    DRUG SAFETY, 2012, 35 (10) : 891 - 891
  • [32] Off-label use in neurology
    Diener, HC
    AKTUELLE NEUROLOGIE, 2002, 29 (08) : 379 - 381
  • [33] A Hemorrhage of Off-Label Use
    Avorn, Jerry
    Kesselheim, Aaron
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 566 - 567
  • [34] QUETIAPINE OFF-LABEL USE
    Levin, R.
    Cosmatos, I
    Dieck, G.
    Reifsnyder, J.
    VALUE IN HEALTH, 2016, 19 (07) : A522 - A522
  • [35] Off-label use of vaccines
    Neels, Pieter
    Southern, James
    Abramson, Jon
    Duclos, Philippe
    Hombach, Joachim
    Marti, Melanie
    Fitzgerald-Husek, Alanna
    Fournier-Caruana, Jacqueline
    Hanquet, Germaine
    VACCINE, 2017, 35 (18) : 2329 - 2337
  • [36] Off-label use of infliximab
    Onder, M.
    Salavastru, C.
    Fritz, K.
    HAUTARZT, 2013, 64 (10): : 757 - 761
  • [37] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
  • [38] Ethical and legal framework and regulation for off-label use: European perspective
    Lenk, Christian
    Duttge, Gunnar
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 537 - 546
  • [39] Off-label use in psychopharmacotherapy [Off-Label-Use in der Psychopharmakotherapie]
    Fritze J.
    Schmauss M.
    Der Nervenarzt, 2002, 73 (8) : 796 - 799
  • [40] Utilization of fentanyl buccal tablets in England: Exploring off-label use reported in a cohort study
    Osborne, V.
    Layton, D.
    Fogg, C.
    Al-Shukri, M.
    Shakir, S. A. W.
    EUROPEAN JOURNAL OF PAIN, 2014, 18 (04) : 506 - 512